Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AB Enzymes
A16AB10 Velaglucerase alfa
D09029 Velaglucerase alfa (USAN) <JP/US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Velaglucerase Alfa
D09029 Velaglucerase alfa (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
395 Enzyme preparations
3959 Others
D09029 Velaglucerase alfa (USAN); Velaglucerase alfa (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Glycosidases
GBA* [HSA_VAR:2629v1]
D09029 Velaglucerase alfa (USAN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09029
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09029
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09029
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09029
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D09029
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16AB Enzymes
A16AB11 Taliglucerase alfa
D09675 Taliglucerase alfa (USAN/INN) <US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Taliglucerase Alfa
D09675 Taliglucerase alfa (USAN/INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Glycosidases
GBA* [HSA_VAR:2629v1]
D09675 Taliglucerase alfa (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09675
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09675
Pharmacogenomic biomarkers [br08341.html]
Germline mutations in genetic disorder treatments
D09675